Curis Stock (NASDAQ: CRIS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 25.469K |
Day Range | - - - |
52 Wk Range | 3.800 - 19.600 |
Market Cap | $97.252M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 1.01% |
Days to Cover | 1.07 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Curis (NASDAQ: CRIS) through any online brokerage.
Other companies in Curis’s space includes: Anixa Biosciences (NASDAQ:ANIX), Cellectar Biosciences (NASDAQ:CLRB), Connect Biopharma Hldgs (NASDAQ:CNTB), Burning Rock Biotech (NASDAQ:BNR) and Barinthus Biotherapeutics (NASDAQ:BRNS).
The latest price target for Curis (NASDAQ: CRIS) was reported by HC Wainwright & Co. on Wednesday, May 8, 2024. The analyst firm set a price target for 26.00 expecting CRIS to rise to within 12 months (a possible 65.39% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Curis (NASDAQ: CRIS) is $15.72 last updated May 10, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Curis.
Curis’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Curis.
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.